Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Koop

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Journal of the International Neuropsychological Society : JINS|September 4, 2008
The relationship of neuropsychological functioning to adaptation outcome in adolescents with spina bifidaAmy K Heffelfinger, Jennifer I Koop, Philip S Fastenau, et al.
Scandinavian Journal of Gastroenterology|August 1, 1996
Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Study Group Members (German Crohn's Disease Study Group)H Lorenz-Meyer, P Bauer, C Nicolay, et al.
Journal of Neurosurgery. Pediatrics|December 15, 2023
Awake craniotomy for supratentorial tumors or epileptogenic lesions in pediatric patients: a 16-year retrospective cohort studyHope M Reecher, Jennifer I Koop, Ahmed J Awad, et al.
Pediatric Neurology|February 1, 2025
Neuropsychology's Role in Multidisciplinary Follow-Up Care of Neurologically Complex Infants and ToddlersLauren E Miller, Danielle M Glad, Jessica C Luepke, et al.
Gut|November 16, 2001
Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapsesW Kruis, S Schreiber, D Theuer, et al.
The American Journal of Pathology|May 4, 2000
Genetic and epigenetic changes in human epithelial cells immortalized by telomeraseD G Farwell, K A Shera, J I Koop, et al.
The Clinical Neuropsychologist|October 31, 2025
Clinical priorities to improve the neuropsychological care of individuals with Spina Bifida: A consensus statement of the Spina Bifida Association and the Spina Bifida and Hydrocephalus Neuropsychology CollaborativeT Andrew Zabel, D J Bernat, Rosalia Costello, et al.
Epilepsy & Behavior : E&B|April 16, 2025
Association of the cognitive lateralization rating Index with surgical variables of a national cohort of pediatric patients with epilepsyHope M Reecher, Sydney E Park, Alyssa Ailion, et al.
Epilepsy & Behavior : E&B|July 31, 2025
Depressive symptoms in youth with refractory epilepsy: Exploration of seizure, sociodemographic and cognitive factorsS B Brothers, C Wolfe-Christensen, H J Loblein, et al.
Epilepsia|March 10, 2023
Leveraging expertise and optimizing clinical research: Initial success of a pediatric epilepsy surgery collaborativeMadison M Berl, Jennifer I Koop, Alyssa Ailion, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Journal of the International Neuropsychological Society : JINS|September 4, 2008
The relationship of neuropsychological functioning to adaptation outcome in adolescents with spina bifidaAmy K Heffelfinger, Jennifer I Koop, Philip S Fastenau, et al.
Scandinavian Journal of Gastroenterology|August 1, 1996
Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Study Group Members (German Crohn's Disease Study Group)H Lorenz-Meyer, P Bauer, C Nicolay, et al.
Journal of Neurosurgery. Pediatrics|December 15, 2023
Awake craniotomy for supratentorial tumors or epileptogenic lesions in pediatric patients: a 16-year retrospective cohort studyHope M Reecher, Jennifer I Koop, Ahmed J Awad, et al.
Pediatric Neurology|February 1, 2025
Neuropsychology's Role in Multidisciplinary Follow-Up Care of Neurologically Complex Infants and ToddlersLauren E Miller, Danielle M Glad, Jessica C Luepke, et al.
Gut|November 16, 2001
Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapsesW Kruis, S Schreiber, D Theuer, et al.
The American Journal of Pathology|May 4, 2000
Genetic and epigenetic changes in human epithelial cells immortalized by telomeraseD G Farwell, K A Shera, J I Koop, et al.
The Clinical Neuropsychologist|October 31, 2025
Clinical priorities to improve the neuropsychological care of individuals with Spina Bifida: A consensus statement of the Spina Bifida Association and the Spina Bifida and Hydrocephalus Neuropsychology CollaborativeT Andrew Zabel, D J Bernat, Rosalia Costello, et al.
Epilepsy & Behavior : E&B|April 16, 2025
Association of the cognitive lateralization rating Index with surgical variables of a national cohort of pediatric patients with epilepsyHope M Reecher, Sydney E Park, Alyssa Ailion, et al.
Epilepsy & Behavior : E&B|July 31, 2025
Depressive symptoms in youth with refractory epilepsy: Exploration of seizure, sociodemographic and cognitive factorsS B Brothers, C Wolfe-Christensen, H J Loblein, et al.
Epilepsia|March 10, 2023
Leveraging expertise and optimizing clinical research: Initial success of a pediatric epilepsy surgery collaborativeMadison M Berl, Jennifer I Koop, Alyssa Ailion, et al.
Pageof 9